article

Drug Target Review – Issue #1 2017

Posted: 9 March 2017 | | No comments yet

Included in this issue: Importance of building patient trust; Vaccines & Immunology; Oncology; Assays; Biomarkers; and Antibodies…

Drug Target Review magazine Issue #1 2017 spread

In Issue #1 2017 of Drug Target Review:

  • Foreword: The importance of building patient trust
    Pamela Brankin, Head of Marketing and Communications, Aridhia
  • In-Depth Focus: Assays
  • Vaccines & Immunology: Bispecific antibodies Q&A
    Lou Matis, Chief Development Officer at Pieris
  • In-Depth Focus: Antibodies
  • Oncology: Targeting GAS6 in cancer, fibrosis and viral infection
    Rebecca Miao and Amato J. Giaccia, Stanford University, and Raymond Tabibiazar, Aravive Biologics
  • Oncology: Nanoparticle-mediated enzyme delivery for application in cancer therapy
    Negin Mokhtari, Mukanth Vaidyanathan, Ya-San Yeh, and Sadik Esener, University of California, San Diego
  • In-Depth Focus: Biomarkers

The digital version of Issue #1 2017 is restricted to logged-in members. Login or become a member now (it's free!) to read it.


 

Webinar: Label-free ultra-high-throughput screening by MALDI Mass SpectrometryWATCH NOW
+ +

Send this to friend